220:
193:
166:
139:
112:
478:
Introduced in 2002, Bard's
Recovery brand IVC filter was associated with 27 deaths and several hundred non-fatal problems. A "confidential study commissioned by Bard showed that the Recovery filter had higher rates of relative risk for death, filter fracture and movement than all of its competitors."
486:
released their investigation of the G2 series filters. According to the NBC report, the G2 filter was just a modified version of the
Recovery filter with "similar and potentially fatal flaws". Bard was reported to be aware of this shortly after the G2 was put on the market, but rather than recalling
442:
By 2010, Bard and other makers of vaginal mesh were being sued by women who alleged that the devices were responsible for their medical pain and injuries. Their legal cases cited poor design and unsafe materials, and claimed that some patients required "multiple surgeries to remove" the device. In
490:
In 2018, an
Arizona court ordered Bard to pay $ 1.6 million to a plaintiff for injuries sustained from a G2 IVC filter implanted in 2007, plus an additional $ 2 million in punitive damages. Bard challenged the verdict, but in October 2020, a court of appeals refused to overturn the ruling.
450:
Although Bard maintained that their vaginal mesh was "safe and effective", they began negotiations in 2013 to settle the nearly 30,000 legal claims. By August 2015, Bard had agreed to pay more than $ 200 million, thereby resolving about one-fifth of the outstanding lawsuits at that time.
418:
In 2006, a complaint was filed against C. R. Bard, alleging that the company paid illegal kickbacks to both physicians and consumers. In 2013, Bard agreed to pay $ 48.26 million to resolve the allegations relating to submitting false claims to
335:
discomfort. The company formally incorporated in 1923, and three years later, in 1926, Charles R. Bard sold the company to John F. Willits and Edson L. Outwin for $ 18,000. Under
Willits and Outwins, the company expanded into the
869:
755:
402:
in 1968. Over time, the company introduced a variety of new health care products, and its net sales first exceeded $ 1 billion in 1994. Around 2012, Bard acquired the company
Lutonix.
930:
642:
27:
487:
the filters, kept them on the market for five years. According to Bard and FDA records, at least 12 deaths and hundreds of problems had been linked to the G2 series filters.
950:
690:
719:
940:
841:
935:
925:
512:
970:
405:
On April 23, 2017, it was announced that C. R. Bard would be bought by BD for $ 24 billion. On
December 29, 2017, the acquisition was completed.
750:
526:
955:
815:
571:
343:
In 1948, C. R. Bard's annual sales topped $ 1 million for the first time, and the company moved its headquarters from New York City to
652:
960:
965:
550:
945:
680:
131:
606:
779:
666:
622:
705:
647:
575:
435:
is a device that is surgically implanted into the vagina to strengthen pelvic muscles or organs, or to treat
444:
902:
300:
company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the
365:
for the first time ever. Bard continued to innovate in the world of catheters, rolling out the bipolar
733:
The live link is to the first of three pages. All content available in a single page via
Archive Link.
447:
required that Bard and other manufacturers study the rates of organ damage linked to the mesh devices.
331:
by
Charles R. Bard in 1907. Bard's first business involved importing Gomenol, which was used to treat
63:
460:
293:
681:"Becton Dickinson buys CR Bard for $ 24 billion to form medical supply giant; Bard shares surge 20%"
420:
399:
395:
312:
265:
479:
Bard never recalled the
Recovery filter, but instead developed G2 series filters to replace it.
379:
in 1960. In 1961, Bard expanded beyond catheters, and began manufacturing products related to
920:
475:
blood clots in the legs from moving into the heart or lungs (a condition that can be fatal).
598:
436:
269:
223:
196:
169:
142:
115:
8:
710:
340:
business, introducing the Foley catheter in 1934 and the
America Woven Catheter in 1940.
590:
780:"C.R. Bard negotiating to settle thousands of lawsuits involving vaginal-mesh implants"
468:
344:
602:
432:
628:
376:
366:
308:
253:
212:
348:
554:
789:
464:
388:
301:
248:
914:
846:
328:
288:
specialty fields. C. R. Bard marketed its products and services worldwide to
358:. Three years later the company began selling Foley catheters that came in
311:. The transaction was completed later that year, and the company became a
870:"9th Circuit upholds bellwether plaintiff's win in Bard IVC filter MDL"
572:"BD Completes Bard Acquisition, Creating New Global Health Care Leader"
538:
380:
355:
297:
158:
37:
643:"Intact Vascular raises $ 15.5M, developing stapler to replace stents"
617:, derived from eucalyptus tree, which relieved his urinary discomfort.
472:
384:
362:
289:
273:
483:
369:
352:
337:
285:
281:
90:
842:"Ninth Circuit Stands by Ruling OKing $ 3.6 Million Bard Judgment"
513:
C.R. Bard (BCR) annual SEC income statement filing via Wikinvest.
359:
332:
307:
In April 2017, C. R. Bard announced that it would be acquired by
277:
784:
527:
C.R. Bard (BCR) annual SEC balance sheet filing via Wikinvest.
296:, extended care facilities, and alternate site facilities. An
751:"Bard Said to Pay $ 200 Million to Settle Vaginal-Mesh Cases"
373:
185:
26:
813:
769:
Archived copy provides free access to full article content.
685:
613:
During a trip to Europe, he encountered a medicine called
931:
Companies formerly listed on the New York Stock Exchange
816:"Why Did Firm Keep Selling Problem Blood-Clot Filters?"
508:
506:
504:
268:, USA, was a developer, manufacturer, and marketer of
706:"Top Whistleblower Settlements of 2013—To Date"
102:
Vascular, Urology, Oncology, and Surgical Specialties
595:
Entrepreneur Magazine Encyclopedia of Entrepreneurs
501:
454:
814:Sandler, Tim; Gosk, Stephanie (31 December 2015).
749:
522:
520:
951:Medical technology companies of the United States
912:
517:
413:
588:
463:(or "blood clot filter") is a device that is
743:
741:
739:
578:. December 29, 2017 – via PR Newswire.
566:
564:
941:Companies based in Union County, New Jersey
809:
807:
591:"Charles R. Bard [C.R. Bard, Inc.]"
634:
25:
936:Health care companies based in New Jersey
926:Health care companies established in 1907
839:
736:
561:
899:Historical business data for C. R. Bard:
867:
804:
589:Hallet, Anthony; Hallett, Diane (1997).
531:
426:
971:American companies established in 1907
913:
722:from the original on November 13, 2013
640:
868:Grzincic, Barbara (August 13, 2020).
747:
703:
956:1907 establishments in New York City
840:Steinberg, Julie (October 1, 2020).
693:from the original on April 24, 2017.
758:from the original on August 8, 2015
704:Tycko, Jonathan (August 31, 2013).
13:
772:
641:George, John (September 5, 2012),
445:Food and Drug Administration (FDA)
347:. In 1954, a Bard scientist, Dr.
309:Becton, Dickinson and Company (BD)
14:
982:
890:
651:, bizjournals.com, archived from
351:(1908-2008), developed the first
455:Inferior vena cava (IVC) filters
327:C. R. Bard, Inc. was founded in
219:
218:
192:
191:
165:
164:
138:
137:
111:
110:
861:
833:
408:
961:1960s initial public offerings
697:
673:
582:
543:
398:in 1963 and was listed on the
1:
966:2017 mergers and acquisitions
748:Feely, Jef (August 4, 2015).
648:Philadelphia Business Journal
576:Becton, Dickinson and Company
494:
254:Becton, Dickinson and Company
553:. Bard. 2017. Archived from
7:
689:. Reuters. April 23, 2017.
414:Illegal kickback settlement
10:
987:
946:New Providence, New Jersey
322:
64:New Providence, New Jersey
539:CR Bard at Yahoo! Finance
461:inferior vena cava filter
294:health care professionals
247:
237:
210:
183:
156:
129:
106:
98:
80:
70:
59:
51:
43:
33:
24:
551:"BD Acquisition of Bard"
471:. It is used to prevent
400:New York Stock Exchange
313:wholly-owned subsidiary
266:Murray Hill, New Jersey
482:On December 31, 2015,
372:in 1958 and the first
16:Pharmaceutical company
667:registration required
623:registration required
599:John Wiley & Sons
792:. September 30, 2013
427:Vaginal mesh devices
315:of BD, rebranded as
270:medical technologies
55:Charles Russell Bard
711:National Law Review
264:, headquartered in
239:Number of employees
21:
655:on August 26, 2014
601:. pp. 27–28.
345:Summit, New Jersey
19:
574:(Press release).
467:implanted in the
433:transvaginal mesh
274:vascular medicine
259:
258:
233:
206:
179:
152:
125:
94:
978:
884:
883:
881:
880:
865:
859:
858:
856:
854:
837:
831:
830:
828:
826:
811:
802:
801:
799:
797:
776:
770:
767:
765:
763:
753:
745:
734:
731:
729:
727:
701:
695:
694:
677:
671:
670:
663:
662:
660:
638:
632:
629:Internet Archive
626:
619:
586:
580:
579:
568:
559:
558:
557:on June 6, 2017.
547:
541:
535:
529:
524:
515:
510:
377:balloon catheter
367:temporary pacing
349:Michael DeBakey
262:C. R. Bard, Inc.
227:
222:
221:
215:
200:
195:
194:
188:
173:
168:
167:
146:
141:
140:
132:Operating income
119:
114:
113:
88:
29:
22:
18:
986:
985:
981:
980:
979:
977:
976:
975:
911:
910:
907:
893:
888:
887:
878:
876:
866:
862:
852:
850:
838:
834:
824:
822:
812:
805:
795:
793:
778:
777:
773:
768:
761:
759:
746:
737:
732:
725:
723:
702:
698:
679:
678:
674:
664:
658:
656:
639:
635:
627:(Full text via
620:
609:
587:
583:
570:
569:
562:
549:
548:
544:
536:
532:
525:
518:
511:
502:
497:
457:
443:2012, the U.S.
429:
416:
411:
325:
240:
211:
184:
161:
134:
87:
86:Timothy M. Ring
83:
73:
17:
12:
11:
5:
984:
974:
973:
968:
963:
958:
953:
948:
943:
938:
933:
928:
923:
909:
908:
906:
905:
900:
896:
892:
891:External links
889:
886:
885:
860:
832:
803:
790:Bloomberg News
771:
735:
696:
672:
633:
607:
581:
560:
542:
530:
516:
499:
498:
496:
493:
465:percutaneously
456:
453:
428:
425:
415:
412:
410:
407:
389:anesthesiology
324:
321:
302:Foley catheter
257:
256:
251:
245:
244:
241:
238:
235:
234:
216:
208:
207:
189:
181:
180:
162:
157:
154:
153:
135:
130:
127:
126:
108:
104:
103:
100:
96:
95:
84:
81:
78:
77:
74:
71:
68:
67:
61:
57:
56:
53:
49:
48:
45:
41:
40:
35:
31:
30:
15:
9:
6:
4:
3:
2:
983:
972:
969:
967:
964:
962:
959:
957:
954:
952:
949:
947:
944:
942:
939:
937:
934:
932:
929:
927:
924:
922:
919:
918:
916:
904:
901:
898:
897:
895:
894:
875:
871:
864:
849:
848:
847:Bloomberg Law
843:
836:
821:
817:
810:
808:
791:
787:
786:
781:
775:
757:
754:. Bloomberg.
752:
744:
742:
740:
721:
717:
713:
712:
707:
700:
692:
688:
687:
682:
676:
668:
654:
650:
649:
644:
637:
630:
624:
618:
616:
610:
608:0-471-17536-6
604:
600:
596:
592:
585:
577:
573:
567:
565:
556:
552:
546:
540:
534:
528:
523:
521:
514:
509:
507:
505:
500:
492:
488:
485:
480:
476:
474:
470:
466:
462:
452:
448:
446:
440:
438:
434:
424:
422:
406:
403:
401:
397:
392:
390:
386:
382:
378:
375:
371:
368:
364:
361:
357:
354:
350:
346:
341:
339:
334:
330:
329:New York City
320:
318:
314:
310:
305:
303:
299:
295:
292:, individual
291:
287:
283:
279:
275:
271:
267:
263:
255:
252:
250:
246:
243:14,000 (2015)
242:
236:
231:
225:
217:
214:
209:
204:
198:
190:
187:
182:
177:
171:
163:
160:
155:
150:
144:
136:
133:
128:
123:
117:
109:
105:
101:
97:
93:) & (CEO)
92:
85:
79:
75:
69:
65:
62:
58:
54:
50:
46:
42:
39:
36:
32:
28:
23:
921:BD (company)
877:. Retrieved
873:
872:. In Brief.
863:
851:. Retrieved
845:
835:
823:. Retrieved
819:
794:. Retrieved
783:
774:
760:. Retrieved
724:. Retrieved
715:
709:
699:
684:
675:
659:September 5,
657:, retrieved
653:the original
646:
636:
614:
612:
594:
584:
555:the original
545:
533:
489:
481:
477:
458:
449:
441:
437:incontinence
430:
417:
409:Legal issues
404:
393:
342:
326:
316:
306:
261:
260:
229:
213:Total equity
202:
186:Total assets
175:
148:
121:
60:Headquarters
34:Company type
903:SEC filings
853:January 16,
726:November 6,
396:went public
394:C. R. Bard
298:S&P 500
72:Area served
915:Categories
879:2023-01-16
762:January 1,
495:References
381:cardiology
356:prosthesis
159:Net income
82:Key people
38:Subsidiary
825:1 January
796:April 15,
473:deep-vein
385:radiology
363:packaging
304:in 1934.
290:hospitals
76:Worldwide
820:NBC News
756:Archived
720:Archived
691:Archived
484:NBC News
421:Medicare
370:catheter
353:arterial
338:catheter
286:surgical
282:oncology
99:Products
91:Chairman
874:Reuters
718:(243).
615:Gomenol
360:sterile
333:urinary
323:History
278:urology
272:in the
230:FY 2010
203:FY 2010
176:FY 2010
149:FY 2010
122:FY 2010
107:Revenue
52:Founder
44:Founded
785:NJ.com
605:
387:, and
284:, and
249:Parent
226:1.63B
199:3.17B
118:2.72B
66:, U.S.
374:latex
172:509M
145:730M
855:2023
827:2016
798:2014
764:2016
728:2013
686:CNBC
661:2012
603:ISBN
431:The
317:Bard
224:US$
197:US$
170:US$
143:US$
116:US$
47:1907
20:Bard
716:III
469:IVC
459:An
423:.
917::
844:.
818:.
806:^
788:.
782:.
738:^
714:.
708:.
683:.
645:,
631:.)
611:.
597:.
593:.
563:^
519:^
503:^
439:.
391:.
383:,
319:.
280:,
276:,
882:.
857:.
829:.
800:.
766:.
730:.
669:)
665:(
625:)
621:(
537:"
232:)
228:(
205:)
201:(
178:)
174:(
151:)
147:(
124:)
120:(
89:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
